Most Popular White Papers
Trade Alert for Chelsea Therapeutics International Ltd.
M2 Presswire, February, 2007
 | Content provided in partnership with |  |
M2 PRESSWIRE-1 February 2007-Biotech News: Trade Alert for Chelsea Therapeutics International Ltd(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:01022007 Trade Alert for Chelsea Therapeutics International Ltd (NASDAQ:CHTP) Chelsea Therapeutics International, Ltd. engages in the acquisition, development, and commercialization of pharmaceutical products for the treatment of immunological diseases.
It has completed phase I trial of its drug candidate, CH-1504, an orally available, metabolically inert, anti-inflammatory, and anti-tumor agent for the treatment of cancers, psoriasis, ...
Read the rest of this article with a Free Trial at HighBeam Research.